Viking Global Investors LP Roivant Sciences Ltd. Transaction History
Viking Global Investors LP
- $29.6 Billion
- Q4 2024
A detailed history of Viking Global Investors LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Viking Global Investors LP holds 47,809,960 shares of ROIV stock, worth $553 Million. This represents 1.91% of its overall portfolio holdings.
Number of Shares
47,809,960
Previous 54,099,066
11.63%
Holding current value
$553 Million
Previous $624 Million
9.4%
% of portfolio
1.91%
Previous 2.42%
Shares
7 transactions
Others Institutions Holding ROIV
# of Institutions
316Shares Held
501MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$761 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$718 Million6.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$472 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$409 Million0.01% of portfolio
-
Morgan Stanley New York, NY34.6MShares$400 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.15B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...